ReviewJournal of oncology2019

Long-Term Survival, Quality of Life, and Psychosocial Outcomes in Advanced Melanoma Patients Treated with Immune Checkpoint Inhibitors.

Anne Rogiers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.